Jul 2026· Human Immunology· Vol 87 9, pp.
111805
· 0 citations· 70 references
Medicine
TL;DR
These computational results suggest that the construct has the potential to induce effective immunity against WELV, however further experimental validations in future have to be performed in order to confirm its efficacy against the pathogen.
Abstract
Background
The tick-borne viruses are primarily transmitted through the bites of infected ticks. Wetland virus (WELV) is a newly identified tick-borne pathogen with no licensed vaccines and limited preventive strategies.
Methods
In this study, a reverse vaccinology approach was used to design a multi-epitope vaccine using the conserved regions of key viral proteins of WELV.
Results
Multiple sequence alignment identified 51, 31, and 5 conserved regions in the RNA-dependent RNA polymerase (R), glycoprotein (G), and nucleocapsid (N) proteins, respectively. The epitope prediction across these regions identified 784 CTL, 933 HTL, and 123 B-cell epitopes, from which antigenic, non-allergenic, and non-toxic candidates were selected for vaccine construction. The final construct was predicted to have favourable antigenicity, solubility, and physicochemical properties. Structural analysis revealed that the construct has a high percentage of random coils (49.02%). Then, the tertiary structure was refined to improve its stereochemical quality, and in the refined structure 96.2% residues were in the most favoured regions. The conformational epitope prediction identified thirteen surface-accessible B-cell epitopes. Molecular docking analysis using HADDOCK showed possible interactions with multiple Toll-like receptors with predicted binding free energies ranging from -13.1 to -15.3 kcal/mol. Codon optimization and in silico cloning were performed to insert the construct into the pET-28a(+) vector. The immune simulation analysis predicted the possibility for inducing effective response, with antibody production, T-cell activation, and long-term immunological memory.
Conclusion
These computational results suggest that the construct has the potential to induce effective immunity against WELV, however further experimental validations in future have to be performed in order to confirm its efficacy against the pathogen.
Computational findings suggest that the designed MESV is a promising vaccine candidate for MARV and warrants further experimental validation through in vitro and in vivo studies.
Asadullah Khan, Sitara Bibi, Pinyi Li et al.· Naunyn-Schmiedeberg's Archiv...· 0 citations
PE/PPE proteins and TCR-recognized immunoreactive peptides are suggested as promising vaccine components against tuberculosis and the designed MEV with the C-terminal fragment of CPE may represent a potential candidate for future development as a mucosal vaccine against M. tuberculosis.
N. Noori Goodarzi, Sepideh Fereshteh, Behzad Shahbazi et al.· Genomics & Informatics· 0 citations
The rationally designed multi-epitope vaccine demonstrates robust theoretical potential to elicit comprehensive, long-lasting immunity in humans, although its safety and effectiveness require additional experimental validation.
Chenchen Yi, Yu Shen, Ye Luo et al.· Frontiers in Cellular and In...· 0 citations
In silico cloning validated the capacity for effective expression in E. coli and secondary structure revealed that the mRNA vaccine was thermodynamically stable, which may contribute to the development of an experimental MARV vaccine.
Utsha Chowdhury, Al Mahmud, Md. Uddin et al.· Journal of Biological Resear...· 0 citations
The study utilizes immunoinformatic-based computational methodology to design multi-epitope subunit vaccine by deciphering highly conserved antigenic epitopes across NiV strains by deciphering highly conserved antigenic epitopes across NiV strains.
Taimoor Khan, T. Ali, Muhammad Suhaib Qudus et al.· Naunyn-Schmiedeberg's Archiv...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.